Komori
Presentation materials for financial results4937Waqoo Inc.Materials and Chemicals

Supplementary Financial Results Presentation for the Third Quarter of the Fiscal Year Ending September 2026

For the first nine months of the fiscal year ending September 2026, revenue and profit increased significantly due to the expansion of the Medical Support business. Operating income turned from a loss in the same period of the previous fiscal year into a profit of ¥415 million. The full-year earnings forecast was revised upward for the second time this fiscal year, with revenue raised to ¥2,750 million and operating income to ¥560 million, among other revisions.

Worth reading
77Important
Scored from 4 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
560
¥ million (revised full-year operating income forecast)
Wording
Conditional
How definitive the wording is.

Contents of this document

Presentation materials for financial resultsQ3 FY20268 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥2,039 million+54.9%
Operating profit¥415 million
Ordinary income¥409 million
Net income¥392 million profit attributable to owners of the parent
Operating profit margin20.4 %
Selling, general and administrative expenses¥1,059 million
Results for the three months of the current quarter
Net Sales
¥905 million
Operating profit
¥277 million
Ordinary income
¥275 million
Net income
¥256 million
Full-year earnings forecast
Net Sales
¥2,750 million
Operating profit
¥560 million
Ordinary income
¥550 million
Net income for the current fiscal year
¥410 million
Operating profit margin
20.4 %
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales74.1 %
Operating profit74.3 %
Ordinary income74.5 %
Net income for the current fiscal year95.8 %
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
All levels of profit are progressing smoothly
New initiatives
  • Second upward revision this fiscal year to the earnings forecast for the fiscal year ending September 2026
  • Introduction of a shareholder benefit program usable at SBC Shonan Beauty Clinic
  • Collaboration with SBC Medical Group on product planning and development, expansion of sales channels, and enhancement of Medical Support operations, among other areas
Key KPIsA metric the company considers important as a management benchmark.
  • Cumulative number of outsourced processing orders21,818 Engagements
    Year on year against the same period last year+163.7%
  • Cumulative number of affiliated clinics844 clinics
    Year on year against the same period last year+135.0%
  • Average outsourced processing orders per day29.3 Engagements
    Year on year against the same period last year+137.6%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Average outsourced processing orders per day
29.3 Engagements
Segment results
Medical Support Business
Net Sales
¥1,312 million
Revenue_yoy_pct128.5
Segment profit
¥330 million
D2C Business
Net Sales
¥543 million
Revenue_yoy_pct-26
Other
Net Sales
¥182 million
Financial targets
Equity ratio
67.8 %
As ofThird quarter of the fiscal year ending September 2026
Number of stores and locations
Number of SBC Medical Group clinics
146 clinics
As ofEnd of June 2026
Domestic and overseas clinic locations
286 Location
As of1 July 2026
Number of employees
101 People
As ofAs of 1 July 2026
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period CoveredQ3 FY2026
Net Sales¥2,039 million (YoY +54.9%)
Operating profit¥415 million
Ordinary income¥409 million
Net income¥392 million (profit attributable to owners of the parent)
Operating profit margin20.4 %
Selling, general and administrative expenses¥1,059 million
Results for the three months of the current quarterNet Sales ¥905 million / Operating profit ¥277 million / Ordinary income ¥275 million / Net income ¥256 million
Full-year earnings forecastNet Sales ¥2,750 million / Operating profit ¥560 million / Ordinary income ¥550 million / Net income for the current fiscal year ¥410 million / Operating profit margin 20.4 %
Progress against full-year forecastNet Sales 74.1 % / Operating profit 74.3 % / Ordinary income 74.5 % / Net income for the current fiscal year 95.8 %
Self-assessment against the planAll levels of profit are progressing smoothly
Segment resultsMedical Support Business Net Sales ¥1,312 million / Revenue_yoy_pct 128.5 / Segment profit ¥330 million / Segment profit YoY % Not disclosed / D2C Business Net Sales ¥543 million / Revenue_yoy_pct -26 / Segment profit Not disclosed / Other Net Sales ¥182 million / Revenue_yoy_pct Not disclosed / Segment profit Not disclosed
Key KPIsIndicator name Cumulative number of outsourced processing orders / Value 21,818 Engagements / Year on year against the same period last year 163.7 Engagements, Indicator name Cumulative number of affiliated clinics / Value 844 clinics / Year on year against the same period last year 135 clinics, Indicator name Average outsourced processing orders per day / Value 29.3 Engagements / Year on year against the same period last year 137.6 Engagements
Unit price and quantity metricsOutsourced processing price / order unit price Not disclosed / Outsourced processing orders / orders received Not disclosed / Average outsourced processing orders per day 29.3 Engagements
Number of stores and locationsNumber of SBC Medical Group clinics 146 clinics / Domestic and overseas clinic locations 286 Location / Number of store openings and closures during the period Not disclosed
Number of employees101 People
Financial targetsEquity ratio 67.8 %
New initiativesSecond upward revision this fiscal year to the earnings forecast for the fiscal year ending September 2026, Introduction of a shareholder benefit program usable at SBC Shonan Beauty Clinic, Collaboration with SBC Medical Group on product planning and development, expansion of sales channels, and enhancement of Medical Support operations, among other areas
Items this document does not state (12)
Gross Profit MarginBreakdown of Factors Affecting the ChangeAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company cited growth in the number of affiliated clinics and outsourced processing orders in the Medical Support business, an earlier-than-planned start-up of operations through its partnership with SBC Medical Group, and restrained advertising investment, stronger sales to existing customers, and greater operating efficiency in the D2C business.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Financial Results Presentation for the Third Quarter of the Fiscal Year Ending September 2026 | Waqoo Inc. (4937) timely disclosure | Komori